信达生物：Entering sustainable profitability with a global innovation engine-20250331

31 Mar 2025 CMB International Global Markets | Equity Research | Company Update Innovent Biologics (1801 HK) Entering sustainable profitability with a global innovation engine Earnings Summary | (YE 31 Dec) | FY23A | FY24A | FY25E | FY26E | FY27E | | --- | --- | --- | --- | --- | --- | | Revenue (RMB mn) | 6,206 | 9,422 | 11,356 | 13,184 | 17,418 | | YoY growth (%) | 36.2 | 51.8 | 20.5 | 16.1 | 32.1 | | Net profit (RMB mn) | (1,027.9) | (94.6) | 445.7 | 757.3 | 2,053.2 | | EPS (Reported) (RMB) | (0.66) | (0 ...